Chimera Translational Research Fraternity Private Limited, a active private limited company, was established on 12 January 2018 in New Delhi, Delhi, India. Engaging in miscellaneous business activities within the business services sector, it holds CIN: U74999DL2018PTC328388. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.
Formerly known as Vimarsh Bio Innovations India Private Limited, Bio Innovations Private Limited. Its leadership includes Vikash Chandra Mishra (Director), Anoushka Raina (Director). Past directors included Nikita Gupta. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 209-C, 2Nd Floor, Masjid Moth South Extension Part-Ii, New Delhi, Delhi, 110049.
U74999DL2018PTC328388
328388
12 January 2018
₹1.00 Cr
₹1.00 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Chimera Translational Research Fraternity Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vikash Chandra Mishra | Director | 12 Jan 2018 | Current |
| Anoushka Raina | Director | 12 Jan 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 19 Feb 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Chimera Translational Research Fraternity Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 9.06% decrease. The company also saw a substantial improvement in profitability, with a 29.61% increase in profit. The company's net worth observed a substantial decline by a decrease of 55.26%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Chimera Translational Research Fraternity's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Chimera Translational Research Fraternity, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Chimera Translational Research Fraternity, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chimera Translational Research Fraternity's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Chimera Translational Research Fraternity Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Chimera Translational Research Fraternity Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
Vikash Chandra Mishra was appointed as a Director was appointed as a Director on 12 Jan 2018 & has been associated with this company since 7 years 10 months . was recorded as a recent event.
The activity Anoushka Raina was appointed as a Director was appointed as a Director on 12 Jan 2018 & has been associated with this company since 7 years 10 months . was completed.
Chimera Translational Research Fraternity Private Limited was registered on 12 Jan 2018 with Roc Delhi & aged 7 years 10 months as per MCA records. was recorded as a recent event.
The CIN of Chimera Translational Research Fraternity Private Limited is U74999DL2018PTC328388.
Chimera Translational Research Fraternity Private Limited is headquartered at 209-C, 2Nd Floor, Masjid Moth South Extension Part-Ii, New Delhi, Delhi, 110049.
Chimera Translational Research Fraternity Private Limited was incorporated on 12 January 2018.
The current directors of Chimera Translational Research Fraternity Private Limited are
The primary industry of Chimera Translational Research Fraternity Private Limited is Business Services.
Chimera Translational Research Fraternity Private Limited is unlisted.
The authorized capital of Chimera Translational Research Fraternity Private Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX